Thus, key metabolic and neurobehavioral dysregulations of BBS were effectively recapitulated in Bbs5–/– mice, which offer a robust platform for dissecting BBS pathophysiology and developing potential therapeutic strategies. This evidence concerns the gene BBS5 and Bardet-Biedl syndrome.